Deep learning synthesis of DBT features from mammography for breast cancer diagnosis.
1/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.7%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[OBJECTIVES] Digital breast tomosynthesis (DBT) enhances diagnostic accuracy by minimizing tissue overlap seen in digital mammography (DM).
- 표본수 (n) 570
- p-value p = 0.002
APA
Fan M, Wang L, et al. (2026). Deep learning synthesis of DBT features from mammography for breast cancer diagnosis.. European journal of radiology, 194, 112486. https://doi.org/10.1016/j.ejrad.2025.112486
MLA
Fan M, et al.. "Deep learning synthesis of DBT features from mammography for breast cancer diagnosis.." European journal of radiology, vol. 194, 2026, pp. 112486.
PMID
41151435 ↗
Abstract 한글 요약
[OBJECTIVES] Digital breast tomosynthesis (DBT) enhances diagnostic accuracy by minimizing tissue overlap seen in digital mammography (DM). However, the substantial number of images generated by DBT poses challenges for radiologists. The aim of this study was to enhance the diagnostic accuracy and clinical utility of DM for breast cancer diagnosis by leveraging advanced feature representations derived from DBT.
[MATERIAL AND METHODS] This retrospective study was approved by the institutional review board of the institute, and samples were consecutively collected from February 2019 to August 2020. Our dataset comprised 806 samples (training: n = 570; testing: n = 236). We developed a cross-modality feature synthesis (CMFS) model to generate synthetic DBT (sDBT) features from DM images. To adeptly capture and analyze structures of varying sizes, such as tumors and their surrounding glandular regions, we designed a ResNet-based multiscale attention network (MSAN). Our generative adversarial network (GAN) model employs multitask learning to convert mammography features into sDBT features for breast cancer diagnosis.
[RESULTS] Our DBT-based model achieved an area under the curve (AUC) of 0.916, utilizing a 32-channel attention bias and the MSAN architecture. Furthermore, the prediction model using the sDBT features generated from DM enhanced lesion classification, improving the AUC from 0.845 to 0.878 (p = 0.002) when relying solely on DM data. Ablation studies validated the crucial components of our model, underscoring its efficacy in breast cancer diagnosis. Model visualizations demonstrated precise lesion localization, and our method enhances the diagnostic value of DM by utilizing DBT data, potentially reducing patient radiation exposure.
[CONCLUSIONS] The proposed CMFS framework improves breast cancer diagnosis by generating sDBT features from DM, enhancing diagnostic accuracy while reducing radiation exposure. Code and models are available at https://github.com/ibml2024/CMFS.
[MATERIAL AND METHODS] This retrospective study was approved by the institutional review board of the institute, and samples were consecutively collected from February 2019 to August 2020. Our dataset comprised 806 samples (training: n = 570; testing: n = 236). We developed a cross-modality feature synthesis (CMFS) model to generate synthetic DBT (sDBT) features from DM images. To adeptly capture and analyze structures of varying sizes, such as tumors and their surrounding glandular regions, we designed a ResNet-based multiscale attention network (MSAN). Our generative adversarial network (GAN) model employs multitask learning to convert mammography features into sDBT features for breast cancer diagnosis.
[RESULTS] Our DBT-based model achieved an area under the curve (AUC) of 0.916, utilizing a 32-channel attention bias and the MSAN architecture. Furthermore, the prediction model using the sDBT features generated from DM enhanced lesion classification, improving the AUC from 0.845 to 0.878 (p = 0.002) when relying solely on DM data. Ablation studies validated the crucial components of our model, underscoring its efficacy in breast cancer diagnosis. Model visualizations demonstrated precise lesion localization, and our method enhances the diagnostic value of DM by utilizing DBT data, potentially reducing patient radiation exposure.
[CONCLUSIONS] The proposed CMFS framework improves breast cancer diagnosis by generating sDBT features from DM, enhancing diagnostic accuracy while reducing radiation exposure. Code and models are available at https://github.com/ibml2024/CMFS.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Deep Learning
- Breast Neoplasms
- Female
- Mammography
- Retrospective Studies
- Radiographic Image Interpretation
- Computer-Assisted
- Sensitivity and Specificity
- Middle Aged
- Breast
- Reproducibility of Results
- Adult
- Cross-modality image generation
- Digital breast tomosynthesis
- Generative adversarial network
- synthetic DBT features
같은 제1저자의 인용 많은 논문 (5)
- Multicolor SERS-encoded immuno-cocktail for longitudinal precise tracking of CTCs phenotypes in lung cancer therapeutics.
- Role of the neurotransmitter-receptor pathway in T-cell tumor immunology and cancer immunotherapy.
- Exploratory Analysis of [ 68 Ga]Ga-FAP-2286 PET/CT Quantitative Parameters for Predicting Response to [ 177 Lu]Lu-FAP-2286 Therapy in Non-small Cell Lung Cancer.
- Joint synthesis of longitudinal MRI and enhanced prediction of neoadjuvant chemotherapy response in breast cancer: a multicohort study.
- Radiomic signatures associated with longitudinal TNM downstaging for prognostic stratification in breast cancer.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.